Corporations Amendment (Remuneration Disclosures) Regulation 2016 (F2016L00514)

17

For an option or right over equity instruments:

(a) issued or issuable by the disclosing entity or any of its subsidiaries; and

(b) held, whether directly, indirectly or beneficially, by any of the following:

(i) each key management person;

(ii) a close member of the family of that person;

(iii) an entity over which the person or the family member has, either directly or indirectly, control, joint control or significant influence

The number of each of the following:

(a) options and rights held at the start of the reporting period;

(b) options and rights granted during the reporting period as compensation;

(c) options and rights exercised during the reporting period;

(d) options and rights resulting from any other change during the reporting period;

(e) options and rights held at the end of the reporting period;

(f) options and rights vested at the end of the reporting period;

(g) options and rights vested and exercisable at the end of the reporting period;

(h) options and rights vested and unexercisable at the end of the reporting period

18

For an equity instrument (other than an option or a right):

(a) issued or issuable by the disclosing entity or any of its subsidiaries; and

(b) held, whether directly, indirectly or beneficially, by any of the following:

(i) each key management person;

(ii) a close member of the family of that person;

(iii) an entity over which the person or the family member has, either directly or indirectly, control, joint control or significant influence

The number of each of the following:

(a) equity instruments held at the start of the reporting period;

(b) equity instruments granted during the reporting period as compensation;

(c) equity instruments received during the reporting period on the exercise of an option or right;

(d) equity instruments resulting from any other change during the reporting period;

(e) equity instruments held at the end of the reporting period;

(f) equity instruments if included in the number disclosed under paragraph (e), held nominally at the end of the reporting period

19

For a transaction (other than share-based payment compensation) that:

(a) involves an equity instrument issued or issuable by the disclosing entity or any of its subsidiaries; and

(b) has occurred, during the reporting period, between the disclosing entity or any of its subsidiaries and any of the following:

(i) a key management person;

(ii) a close member of the family of that person;

(iii) an entity over which the person or the family member has, either directly or indirectly, control, joint control or significant influence;

if the terms or conditions of the transaction were more favourable than those that it is reasonable to expect the entity would adopt if dealing at arms-length with an unrelated person

(a) The nature of each different type of transaction

(b) For each transaction, the terms and conditions of the transaction